Literature DB >> 27061561

Decitabine+ CAG +DLI in relapsed acute myeloid leukemia after allogeneic stem cell transplantation.

Bianhong Wang1, Xiangshu Jin, Quanshun Wang, Yu Jing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27061561

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


× No keyword cloud information.
  4 in total

Review 1.  Hypomethylating agents after allogeneic blood stem cell transplantation.

Authors:  Thomas Schroeder; Christina Rautenberg; Rainer Haas; Guido Kobbe
Journal:  Stem Cell Investig       Date:  2016-11-28

Review 2.  Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation.

Authors:  Thomas Schroeder; Christina Rautenberg; Rainer Haas; Ulrich Germing; Guido Kobbe
Journal:  Int J Hematol       Date:  2017-11-15       Impact factor: 2.490

3.  Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors.

Authors:  Carmine Liberatore; Maria Teresa Lupo Stanghellini; Francesca Lorentino; Luca Vago; Matteo Giovanni Carrabba; Raffaella Greco; Sarah Marktel; Andrea Assanelli; Francesca Farina; Consuelo Corti; Massimo Bernardi; Jacopo Peccatori; Katja Sockel; Jan Moritz Middeke; Johannes Schetelig; Anika Bergmann; Christina Rautenberg; Fabio Ciceri; Martin Bornhäuser; Thomas Schroeder; Friedrich Stölzel
Journal:  Ther Adv Hematol       Date:  2022-06-17

4.  Decitabine combined with CAG regimen in the treatment of elderly patients with acute myeloid leukemia.

Authors:  Haitao Zhao; Chunyan Wang; Fengying Yu; Qingwei Guo
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.